Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 162,050 | 136,537 | 175,380 | 253,504 | 193,067 |
| Receivables | 228,622 | 210,166 | 202,658 | 185,275 | 177,555 |
| Inventories | 77,169 | 75,681 | 72,362 | 71,821 | 69,036 |
| Other current assets | 59,706 | 59,855 | 50,693 | 49,130 | 86,725 |
| TOTAL | $527,547 | $482,239 | $501,093 | $559,730 | $526,383 |
| Non-Current Assets | |||||
| PPE Net | 622,492 | 566,145 | 534,745 | 460,856 | 440,348 |
| Intangibles | 1,277,792 | 1,278,757 | 1,279,513 | 1,252,728 | 1,262,234 |
| Other Non-Current Assets | 236,248 | 241,253 | 242,193 | 229,901 | 388,121 |
| TOTAL | $2,136,532 | $2,086,155 | $2,056,451 | $1,943,485 | $2,090,703 |
| Total Assets | $2,664,079 | $2,568,394 | $2,557,544 | $2,503,215 | $2,617,086 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 24,098 | 25,759 | 24,970 | 24,116 | 36,724 |
| Accounts payable and accrued liabilities | 35,707 | 37,256 | 28,223 | 23,681 | 26,813 |
| Accrued Expenses | 96,780 | 73,978 | 83,642 | 70,285 | 69,899 |
| Other current liabilities | 18,017 | 20,322 | 25,632 | 36,318 | 27,367 |
| TOTAL | $269,681 | $246,290 | $259,331 | $253,581 | $275,123 |
| Non-Current Liabilities | |||||
| Long Term Debt | 511,816 | 527,555 | 547,084 | 576,542 | 571,808 |
| Deferred Revenues | 94,963 | 88,526 | 93,197 | 78,941 | 82,352 |
| Other Non-Current Liabilities | 152,714 | 152,331 | 155,918 | 119,570 | 129,165 |
| TOTAL | $664,530 | $679,886 | $703,002 | $696,112 | $700,973 |
| Total Liabilities | $934,211 | $926,176 | $962,333 | $949,693 | $976,096 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,907 | 67,304 | 66,933 | 66,902 | 68,309 |
| Common Shares | 747 | 739 | 734 | 733 | 730 |
| Retained earnings | 97,842 | 59,886 | 23,123 | -12,066 | 4,540 |
| Other shareholders' equity | 42,411 | 25,380 | 21,216 | 23,621 | 28,491 |
| TOTAL | $1,729,868 | $1,642,218 | $1,595,211 | $1,553,522 | $1,640,990 |
| Total Liabilities And Equity | $2,664,079 | $2,568,394 | $2,557,544 | $2,503,215 | $2,617,086 |